Literature DB >> 14751563

Transforming growth factor-beta induces osteoclast formation in the absence of RANKL.

I Itonaga1, A Sabokbar, S G Sun, O Kudo, L Danks, D Ferguson, Y Fujikawa, N A Athanasou.   

Abstract

Transforming growth factor beta (TGFbeta) is a multifunctional growth factor that is produced by many cells in bone and is abundant in the bone matrix. TGFbeta is known to regulate RANKL-induced osteoclast formation and bone resorbing activity. In this study we sought to determine whether TGFbeta could directly induce osteoclast formation by a RANKL-independent mechanism. We found that the addition of TGFbeta to cultures of human monocytes and RAW 264.7 cells (in the presence of M-CSF and the absence of RANKL, TNFalpha or IL-6/IL-11) was sufficient to induce the formation of TRAP+ and VNR+ cells, which formed actin rings and were capable of extensive lacunar resorption. The addition of osteoprotegerin or antibodies to TNFalpha and its receptors, as well as antibodies to gp130, did not inhibit lacunar resorption, indicating that TGFbeta did not act by stimulating RANKL, TNF or IL-6 production by monocytes. TGFbeta-induced osteoclast formation was qualitatively different from that induced by RANKL with numerous TRAP+/VNR+ mononuclear and small multinucleated cells being formed; these cells produced many small resorption lacunae. Our results indicate that TGFbeta, which is abundant in the bone matrix, can, in the presence of M-CSF, directly induce mononuclear phagocyte osteoclast precursors to differentiate into osteoclastic cells capable of lacunar resorption.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14751563     DOI: 10.1016/j.bone.2003.08.008

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  34 in total

1.  The effects on bone cells of metal ions released from orthopaedic implants. A review.

Authors:  Valerio Sansone; Davide Pagani; Marco Melato
Journal:  Clin Cases Miner Bone Metab       Date:  2013-01

2.  Interleukin-15-activated natural killer cells kill autologous osteoclasts via LFA-1, DNAM-1 and TRAIL, and inhibit osteoclast-mediated bone erosion in vitro.

Authors:  Shan Feng; Suzi H Madsen; Natasja N Viller; Anita V Neutzsky-Wulff; Carsten Geisler; Lars Karlsson; Kalle Söderström
Journal:  Immunology       Date:  2015-05-19       Impact factor: 7.397

3.  RANKL cytokine enhances TNF-induced osteoclastogenesis independently of TNF receptor associated factor (TRAF) 6 by degrading TRAF3 in osteoclast precursors.

Authors:  Zhenqiang Yao; Wei Lei; Rong Duan; Yanyun Li; Lu Luo; Brendan F Boyce
Journal:  J Biol Chem       Date:  2017-04-24       Impact factor: 5.157

Review 4.  Non-Canonical (RANKL-Independent) Pathways of Osteoclast Differentiation and Their Role in Musculoskeletal Diseases.

Authors:  A Sabokbar; D J Mahoney; F Hemingway; N A Athanasou
Journal:  Clin Rev Allergy Immunol       Date:  2016-08       Impact factor: 8.667

5.  The c.29T>C polymorphism of the transforming growth factor beta-1 (TGFB1) gene, bone mineral density and the occurrence of low-energy fractures in patients with inflammatory bowel disease.

Authors:  I Krela-Kaźmierczak; M Michalak; A Wawrzyniak; A Szymczak; P Eder; L Łykowska-Szuber; M Kaczmarek-Ryś; N Drwęska-Matelska; M Skrzypczak-Zielińska; K Linke; R Słomski
Journal:  Mol Biol Rep       Date:  2017-10-09       Impact factor: 2.316

6.  Suppressive effects of Anoectochilus formosanus extract on osteoclast formation in vitro and bone resorption in vivo.

Authors:  Kikuko Masuda; Mayumi Ikeuchi; Tomoyuki Koyama; Kohji Yamaguchi; Je-Tae Woo; Tomio Nishimura; Kazunaga Yazawa
Journal:  J Bone Miner Metab       Date:  2008-02-27       Impact factor: 2.626

Review 7.  Targeting mast cells in gastric cancer with special reference to bone metastases.

Authors:  Christian Leporini; Michele Ammendola; Ilaria Marech; Giuseppe Sammarco; Rosario Sacco; Cosmo Damiano Gadaleta; Caroline Oakley; Emilio Russo; Giovambattista De Sarro; Girolamo Ranieri
Journal:  World J Gastroenterol       Date:  2015-10-07       Impact factor: 5.742

8.  Immunology of Gut-Bone Signaling.

Authors:  Fraser L Collins; Jonathan D Schepper; Naiomy Deliz Rios-Arce; Michael D Steury; Ho Jun Kang; Heather Mallin; Daniel Schoenherr; Glen Camfield; Saima Chishti; Laura R McCabe; Narayanan Parameswaran
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

9.  Biological effects of rinsing morsellised bone grafts before and after impaction.

Authors:  Gerjon Hannink; Ester Piek; Jose M A Hendriks; Peter M Van der Kraan; B Willem Schreurs; Pieter Buma
Journal:  Int Orthop       Date:  2008-01-16       Impact factor: 3.075

10.  Interleukin-32 promotes osteoclast differentiation but not osteoclast activation.

Authors:  Guillaume Mabilleau; Afsie Sabokbar
Journal:  PLoS One       Date:  2009-01-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.